BFSG LLC’s Elanco Animal Health ELAN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$218K Sell
8,842
-2,184
-20% -$50.5K 0.02% 292
2026
Q1
$264K Sell
11,026
-3,080
-22% -$75.3K 0.03% 236
2025
Q4
$319K Sell
14,106
-1,867
-12% -$40.6K 0.03% 220
2025
Q3
$322K Sell
15,973
-11,000
-41% -$184K 0.03% 228
2025
Q2
$385K Buy
26,973
+1,321
+5% +$15.4K 0.04% 195
2025
Q1
$269K Buy
25,652
+1,098
+4% +$12.4K 0.03% 207
2024
Q4
$297K Buy
24,554
+7,191
+41% +$94.1K 0.03% 203
2024
Q3
$255K Buy
17,363
+3,297
+23% +$45.9K 0.03% 226
2024
Q2
$203K Sell
14,066
-819
-6% -$13.1K 0.03% 235
2024
Q1
$242K Buy
14,885
+1,125
+8% +$17.6K 0.03% 218
2023
Q4
$205K Sell
13,760
-2,801
-17% -$31.7K 0.03% 233
2023
Q3
$186K Buy
+16,561
New +$192K 0.03% 225
2022
Q4
Sell
-14,826
Closed -$184K 188
2022
Q3
$184K Buy
14,826
+820
+6% +$14.3K 0.04% 174
2022
Q2
$275K Buy
14,006
+648
+5% +$15.3K 0.05% 177
2022
Q1
$349K Buy
13,358
+2,173
+19% +$57.9K 0.06% 170
2021
Q4
$317K Buy
+11,185
New +$348K 0.04% 197

Other funds holding ELAN

BFSG LLC's ELAN Position: Q2 2026 in Review

BFSG LLC reduced its Elanco Animal Health (ELAN) stake by 20% in Q2 2026, selling an estimated $50.5K and leaving 8,842 shares worth $218K. The position accounts for 0.02% of the portfolio, ranked #292.

BFSG LLC first reported a position in ELAN in Q4 2021 and has held it in 16 quarters since. The position peaked at $385K in Q2 2025. 522 funds tracked by Wall St. Rank hold ELAN as of Q2 2026.

  • BFSG LLC held 8,842 shares of Elanco Animal Health worth $218K as of Q2 2026.
  • BFSG LLC sold 2,184 Elanco Animal Health shares in Q2 2026, an estimated $50.5K.
  • Elanco Animal Health made up 0.02% of BFSG LLC's portfolio in Q2 2026, its #292 holding.
  • BFSG LLC first reported a position in Elanco Animal Health in Q4 2021 and has held it in 16 quarters since.
  • BFSG LLC's Elanco Animal Health position peaked at $385K in Q2 2025.
  • 522 funds tracked by Wall St. Rank held Elanco Animal Health as of Q2 2026.

Based on BFSG LLC's 13F filing for Q2 2026, filed 20 Jul 2026.